Twilight Bioscience, Inc.
PrivateLast Round
Grant
Feb 1, 2025
Total Funding Raised
$3.3M
Company Overview
Twilight Bioscience, Inc. is a biotechnology company that develops precision active immunotherapies for chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Twilight Bioscience, Inc. Comparables
Compare Twilight Bioscience, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vaxxinity, Inc. | 78% | |
| Nuravax | 76% | |
| AC Immune SA | 71% | |
Twilight Bioscience, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2025 | ||||
| Seed | Sep 1, 2022 |
Twilight Bioscience, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Formation Venture Engineering | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2022
$3M round with Formation Venture Engineering and Akston Biosciences.
Twilight Bioscience, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Twilight Bioscience, Inc.'s valuation, stock price, and market status.